MAPS Statement on FDA Complete Response Letter on MDMA-Assisted Therapy for PTSD New Drug Application

7 months ago

MAPS remains confident in its goal of making access to MDMA-assisted therapy for PTSD safe and legal Aug 9, 2024 – San Jose, CA – The Multidisciplinary Association for Psychedelic Studies (MAPS) is evaluating the path forward for safe, legal access to MDMA-assisted therapy following the announcement from Lykos Therapeutics that the potential approval of midomafetamine  […]